With $2.1 million price tag, families fight to get the lifesaving drug for babies covered

When the Food and Drug Administration approved Zolgensma, a lifesaving medication to treat spinal muscular atrophy, parents of young children with the rare and fatal disease rejoiced. But that relief was quickly tempered by the price tag: $2.1 million — the…